Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
50.5% lost 15% or more of their body weight compared to 4.9% of the placebo group
Researchers commonly investigate IGF-1 LR3 Peptide for its role in muscle hypertrophy models, recovery signaling, and cellular proliferation pathways
In phase 3 trials, maximal dose retatrutide demonstrated 29% placebo-adjusted weight loss at 68 weeks (albeit with higher discontinuation rates than semaglutide and tirzepatide)
Take a sneak peek at what the future holds as we explore new avenues with this medicine in this area
US$ 20.62
US$ 23.64
US$ 22.01
US$ 27.77
US$ 26.53
US$ 20.36
US$ 25.18
US$ 22.49
